Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Accumulated Depreciation: 2013-2024

  • Ocular Therapeutix's Accumulated Depreciation rose 16.64% to $23.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $23.6 million, marking a year-over-year increase of 16.64%. This contributed to the annual value of $23.6 million for FY2024, which is 16.64% up from last year.
  • Per Ocular Therapeutix's latest filing, its Accumulated Depreciation stood at $23.6 million for Q4 2024, which was up 16.64% from $20.3 million recorded in Q4 2023.
  • In the past 5 years, Ocular Therapeutix's Accumulated Depreciation registered a high of $23.6 million during Q4 2024, and its lowest value of $12.8 million during Q4 2020.
  • Over the past 3 years, Ocular Therapeutix's median Accumulated Depreciation value was $20.3 million (recorded in 2023), while the average stood at $20.4 million.
  • Data for Ocular Therapeutix's Accumulated Depreciation shows a peak YoY increased of 27.62% (in 2020) over the last 5 years.
  • Quarterly analysis of 5 years shows Ocular Therapeutix's Accumulated Depreciation stood at $12.8 million in 2020, then climbed by 18.93% to $15.2 million in 2021, then climbed by 13.62% to $17.3 million in 2022, then grew by 17.26% to $20.3 million in 2023, then grew by 16.64% to $23.6 million in 2024.
  • Its last three reported values are $23.6 million in Q4 2024, $20.3 million for Q4 2023, and $17.3 million during Q4 2022.